Patents/Assignees

Bright Peak Therapeutics AG

3 patents in portfolio

US12383631utility2025
Immune Antigen Specific IL-18 Immunocytokines and Uses Thereof
0 cites
US12173062utility2024
Modified Tnf-α Antibodies and Uses Thereof
0 cites
US11633488utility2023
Modified IL-2 Polypeptides and Uses Thereof
0 cites